NO20015995L - Metode for inhibering av amyloid-protein-aggregering og billeddannelse av amyloid-avleiringer - Google Patents
Metode for inhibering av amyloid-protein-aggregering og billeddannelse av amyloid-avleiringerInfo
- Publication number
- NO20015995L NO20015995L NO20015995A NO20015995A NO20015995L NO 20015995 L NO20015995 L NO 20015995L NO 20015995 A NO20015995 A NO 20015995A NO 20015995 A NO20015995 A NO 20015995A NO 20015995 L NO20015995 L NO 20015995L
- Authority
- NO
- Norway
- Prior art keywords
- amyloid
- imaging
- protein aggregation
- inhibiting
- deposits
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
- C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/62—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino groups and at least two carboxyl groups bound to carbon atoms of the same six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13855099P | 1999-06-10 | 1999-06-10 | |
PCT/US2000/015071 WO2000076489A2 (en) | 1999-06-10 | 2000-05-31 | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015995D0 NO20015995D0 (no) | 2001-12-07 |
NO20015995L true NO20015995L (no) | 2002-02-04 |
Family
ID=22482537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015995A NO20015995L (no) | 1999-06-10 | 2001-12-07 | Metode for inhibering av amyloid-protein-aggregering og billeddannelse av amyloid-avleiringer |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP1225886A2 (zh) |
JP (1) | JP2003504310A (zh) |
KR (1) | KR20020008224A (zh) |
CN (1) | CN1378446A (zh) |
AP (1) | AP2002002387A0 (zh) |
AU (1) | AU775157B2 (zh) |
BG (1) | BG106293A (zh) |
BR (1) | BR0011728A (zh) |
CA (1) | CA2375551A1 (zh) |
CR (1) | CR6528A (zh) |
DZ (1) | DZ3252A1 (zh) |
EA (1) | EA004632B1 (zh) |
EE (1) | EE200100673A (zh) |
GE (1) | GEP20053423B (zh) |
HK (1) | HK1048258A1 (zh) |
HR (1) | HRP20020026A2 (zh) |
HU (1) | HUP0202508A3 (zh) |
IL (1) | IL146971A0 (zh) |
IS (1) | IS6193A (zh) |
MA (1) | MA26805A1 (zh) |
MX (1) | MXPA01012318A (zh) |
NO (1) | NO20015995L (zh) |
NZ (1) | NZ515621A (zh) |
OA (1) | OA11963A (zh) |
PL (1) | PL352430A1 (zh) |
SK (1) | SK17632001A3 (zh) |
TR (1) | TR200103551T2 (zh) |
WO (1) | WO2000076489A2 (zh) |
YU (1) | YU86701A (zh) |
ZA (1) | ZA200109794B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070667A1 (fr) * | 2000-03-22 | 2001-09-27 | Bf Research Institute, Inc. | Sonde de diagnostic par image, a base d'azobenzene substitue ou d'un analogue de celui-ci, pour les maladies imputables a l'accumulation d'amyloide et composition pour le diagnostic par image le contenant |
CA2357450A1 (en) * | 2000-09-29 | 2002-03-29 | Warner-Lambert Company | Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosis |
GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
ES2327372B1 (es) * | 2007-04-23 | 2010-08-24 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
AU2008215948A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of AD and related conditions |
US20080253967A1 (en) * | 2007-04-13 | 2008-10-16 | Kung Hank F | Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques |
UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
EP2135610A1 (en) | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
CA2735158C (en) | 2008-08-29 | 2016-11-08 | Treventis Corporation | Compositions and methods of treating amyloid disease |
EP2228367A1 (en) * | 2009-03-13 | 2010-09-15 | Almirall, S.A. | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
WO2011101787A1 (en) * | 2010-02-16 | 2011-08-25 | Università Degli Studi Di Siena | Non peptidic 14-3-3 inhibitors and the use thereof |
WO2012071186A1 (en) * | 2010-11-24 | 2012-05-31 | Allergan, Inc. | Modulators of s1p receptors |
US11555009B2 (en) * | 2017-03-02 | 2023-01-17 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | 2-(substituted benzene matrix) aromatic formate FTO inhibitor, preparation method therefor, and applications thereof |
JP7205830B2 (ja) * | 2017-08-07 | 2023-01-17 | 国立大学法人広島大学 | 新規アントラニル酸系化合物、並びにそれを用いたPin1阻害剤、炎症性疾患の治療剤及び癌の治療剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
US5739169A (en) * | 1996-05-31 | 1998-04-14 | Procept, Incorporated | Aromatic compounds for inhibiting immune response |
ES2223531T3 (es) * | 1999-06-10 | 2005-03-01 | Warner-Lambert Company Llc | Metodo de inhibir la agregacion de proteinas amiloides y de formacion de imagenes de depositos amiloides usando derivados de isoindolina. |
-
2000
- 2000-05-31 WO PCT/US2000/015071 patent/WO2000076489A2/en not_active Application Discontinuation
- 2000-05-31 CN CN00808672A patent/CN1378446A/zh active Pending
- 2000-05-31 EP EP00939471A patent/EP1225886A2/en not_active Withdrawn
- 2000-05-31 CA CA002375551A patent/CA2375551A1/en not_active Abandoned
- 2000-05-31 JP JP2001502823A patent/JP2003504310A/ja active Pending
- 2000-05-31 OA OA1200100327A patent/OA11963A/en unknown
- 2000-05-31 TR TR2001/03551T patent/TR200103551T2/xx unknown
- 2000-05-31 GE GE4687A patent/GEP20053423B/en unknown
- 2000-05-31 BR BR0011728-5A patent/BR0011728A/pt not_active IP Right Cessation
- 2000-05-31 AU AU54553/00A patent/AU775157B2/en not_active Ceased
- 2000-05-31 AP APAP/P/2002/002387A patent/AP2002002387A0/en unknown
- 2000-05-31 KR KR1020017015879A patent/KR20020008224A/ko not_active Application Discontinuation
- 2000-05-31 EE EEP200100673A patent/EE200100673A/xx unknown
- 2000-05-31 NZ NZ515621A patent/NZ515621A/en unknown
- 2000-05-31 SK SK1763-2001A patent/SK17632001A3/sk unknown
- 2000-05-31 DZ DZ003252A patent/DZ3252A1/fr active
- 2000-05-31 PL PL00352430A patent/PL352430A1/xx not_active Application Discontinuation
- 2000-05-31 HU HU0202508A patent/HUP0202508A3/hu unknown
- 2000-05-31 YU YU86701A patent/YU86701A/sh unknown
- 2000-05-31 IL IL14697100A patent/IL146971A0/xx unknown
- 2000-05-31 MX MXPA01012318A patent/MXPA01012318A/es not_active Application Discontinuation
- 2000-05-31 EA EA200101135A patent/EA004632B1/ru not_active IP Right Cessation
-
2001
- 2001-11-28 ZA ZA200109794A patent/ZA200109794B/en unknown
- 2001-12-07 CR CR6528A patent/CR6528A/es not_active Application Discontinuation
- 2001-12-07 IS IS6193A patent/IS6193A/is unknown
- 2001-12-07 NO NO20015995A patent/NO20015995L/no not_active Application Discontinuation
-
2002
- 2002-01-02 MA MA26463A patent/MA26805A1/fr unknown
- 2002-01-09 BG BG106293A patent/BG106293A/xx unknown
- 2002-01-10 HR HR20020026A patent/HRP20020026A2/hr not_active Application Discontinuation
-
2003
- 2003-01-16 HK HK03100404.7A patent/HK1048258A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0202508A3 (en) | 2003-03-28 |
BG106293A (en) | 2002-06-28 |
OA11963A (en) | 2006-04-17 |
GEP20053423B (en) | 2005-01-25 |
WO2000076489A2 (en) | 2000-12-21 |
EE200100673A (et) | 2003-02-17 |
EA200101135A1 (ru) | 2002-06-27 |
YU86701A (sh) | 2004-09-03 |
DZ3252A1 (zh) | 2000-12-21 |
BR0011728A (pt) | 2002-02-26 |
SK17632001A3 (sk) | 2003-03-04 |
AU5455300A (en) | 2001-01-02 |
MXPA01012318A (es) | 2002-07-22 |
NZ515621A (en) | 2004-05-28 |
NO20015995D0 (no) | 2001-12-07 |
EA004632B1 (ru) | 2004-06-24 |
IS6193A (is) | 2001-12-07 |
EP1225886A2 (en) | 2002-07-31 |
ZA200109794B (en) | 2003-07-01 |
AU775157B2 (en) | 2004-07-22 |
IL146971A0 (en) | 2002-08-14 |
AP2002002387A0 (en) | 2002-03-31 |
HRP20020026A2 (en) | 2003-08-31 |
CR6528A (es) | 2004-02-23 |
TR200103551T2 (tr) | 2002-12-23 |
HK1048258A1 (zh) | 2003-03-28 |
WO2000076489A3 (en) | 2002-05-30 |
CN1378446A (zh) | 2002-11-06 |
HUP0202508A2 (hu) | 2002-12-28 |
CA2375551A1 (en) | 2000-12-21 |
PL352430A1 (en) | 2003-08-25 |
KR20020008224A (ko) | 2002-01-29 |
JP2003504310A (ja) | 2003-02-04 |
MA26805A1 (fr) | 2004-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20015992D0 (no) | Fremgangsmåte for inhibering av amyloidprotein aggregering og billeddannelse av amyloiddeponeringer under anvendelse avisoindolinderivater | |
NO20015995L (no) | Metode for inhibering av amyloid-protein-aggregering og billeddannelse av amyloid-avleiringer | |
NO20014504D0 (no) | Anordning og fremgangsmåte for rehabilitering av tinnitus | |
NO20001544L (no) | FremgangsmÕte og anordning for prøvetakning av formasjonsfluid | |
NO20014046D0 (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
NO20022592L (no) | Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner | |
NO20006299D0 (no) | Undervanns brönnanordning og fremgangsmåte for produksjon av fluider fra en undervanns brönn | |
DE60204932D1 (de) | Toner und Bildaufzeichnungsmethode | |
NO985484L (no) | FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi | |
DE60001143D1 (de) | Bildverarbeitungsvorrichtung und -verfahren und Aufzeichnungsmedium | |
IS6242A (is) | Aðferð og búnaður til að ákvarða gæðaeiginleika fisks | |
NO20006422L (no) | Fremgangsmåte for utförelse av nede-i-hulls kompletteringsrengjöring og tilhörende anordning for samme | |
DE60021321D1 (de) | Bilderzeugungsverfahren und Gerät | |
DE69921926D1 (de) | Bilderzeugungsgerät und Verfahren | |
DE60001791D1 (de) | Bilderzeugungsgerät und -Verfahren | |
DE60008820D1 (de) | Bilderzeugungsverfahren und Bilderzeugungsgerät | |
DE60033338D1 (de) | Toner und Bildaufzeichungsverfahren | |
NO991577D0 (no) | FremgangsmÕte og system for testing av borehull | |
NO20021352D0 (no) | Filteranordning og fremgangsmåte for rensing av anordningens filtreringselementer | |
NO20023737D0 (no) | Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse | |
NO20012729L (no) | Anordning og fremgangsmåte for behandling og gruspakking av soner beliggende i n¶rheten av hverandre | |
NO20022990D0 (no) | Fremgangsmåte og sammensetning for behandling av smerte | |
NO20003881D0 (no) | Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber | |
NO20042492L (no) | Fremgangsmate for deteksjon og karakterisering av avleiringer i sanntid | |
NO20005080D0 (no) | FremgangsmÕte og anordning for maskinell oppdeling av flatfisk i porsjonsstykker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |